FDA.reportPublic FDA data

Lipoprotein A IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used for the quantitative measurement of lipoprotein A lipid in a clinical specimen.
GUDID devices
12
Last updated
2026-06-04 19:44:10

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
00630414285016N Lp(a) Control SYSiemens Healthcare Diagnostics Products GmbH108736872020-05-29
B085K743M50Audit MicroControls Linearity FD Lipoprotein (a)AALTO SCIENTIFICK743M-52025-11-20
08058056681744Lp(a) Control SetSENTINEL CH. SPA11522012024-03-15
05055273204445LIPOPROTEIN (a) CONTROL (Lp (a) CONTROL 3) RANDOX LABORATORIES LIMITEDLP34062022-10-05
00811727015594Pointe Lipoprotein (a) Control SetHORIBA INSTRUMENTS INCORPORATEDL7597-CTL2021-01-30
00842768007248N Lp(a) Control SYSiemens Healthcare Diagnostics Products GmbH104460402020-09-24
00630414287447N Lp(a) Control SYSiemens Healthcare Diagnostics Products GmbH108736872020-05-29
00380740157449ARCHITECTABBOTT LABORATORIES05P84112020-03-03
00380740153823AlinityABBOTT LABORATORIES01R14102019-05-10
00817089020375DiazymeDIAZYME LABORATORIES, INC.DZ131A-CON2016-11-03
00817089020399DiazymeDIAZYME LABORATORIES, INC.DZ131B-CON2016-11-03
00380740100933ARCHITECTABBOTT LABORATORIES5P84-102016-09-09